L
Liki24
Building an ecosystem that unites pharmacies, logistics, insurance companies, clinics, doctors, telemedicine, healthcare products producers, and all other market players
About Liki24
Liki24.com operates as a healthcare delivery platform that bridges the gap between pharmacies and customers, ensuring fast and reliable medication delivery. The company primarily serves individuals who require timely access to medications, including prescription drugs, over-the-counter products, and health-related items. Operating in the healthcare and logistics market, Liki24.com leverages a network of partner pharmacies and a fleet of couriers to fulfill customer orders efficiently.
The business model revolves around aggregating products from various pharmacies and offering them through a user-friendly online platform. Customers can place orders via the website or mobile app, and Liki24.com coordinates the procurement and delivery process. Revenue is generated through service fees charged to customers for delivery and through partnerships with pharmacies that benefit from increased sales and customer reach.
Liki24.com stands out by providing a seamless and convenient solution for medication delivery, addressing the needs of customers who may have mobility issues, time constraints, or prefer the convenience of home delivery. The platform also offers price comparisons, helping customers find the best deals on their medications.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Kyiv, Ukraine
- Employees
- 61
- Open positions
- None listed
- Dealroom signal
- 82.3/100
- Industry
- Health, Transportation
- Sub-industry
- Pharmaceutical, Health Platform, Logistics & Delivery
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Digital Pharma
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2025 | $9M | $36M | Sid Venture Partners · Anton Borzov · Dnipro VC · N1 Ventures | ↗ |
| GRANT✓Other financing | Jul 2024 | $28K | — | Seeds of Bravery | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Liki24 is 430K monthly website visits, down 21.8% over the last three months. Liki24's team grew 7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Seeds of Bravery
Series A11 investors entered at this stage
TA Ventures
Horizon Capital
Missiontech.co
ICLUB Global
Flyer One Ventures
Sid Venture Partners- ABAnton Borzov
Dnipro VC
N1 Ventures
MA7 Ventures
U.ventures
Other known investors3 additional known investors
Google for Startups Accelerator
Google for Startups Ukraine Support Fund
Slava Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Liki24 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Liki24’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.